当前位置:首页 - 行情中心 - 九强生物(300406) - 财务分析

九强生物

(300406)

  

流通市值:57.00亿  总市值:78.74亿
流通股本:4.24亿   总股本:5.86亿

九强生物(300406)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润2.73亿元,每股收益0.46元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益399523.25万元,未分配利润265324.10万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产529504.67万元,负债129981.42万元。

利润表
报告期2025-09-302025-06-302025-03-312024-12-31
营业总收入1,011,713,943.43668,335,957.13319,809,793.711,658,931,975.39
营业总成本694,610,808.39461,501,647.18222,735,370.831,056,135,883.84
其他经营收益
营业利润307,842,002.72196,826,91098,056,421.38624,050,562.29
利润总额306,960,707.65196,384,262.1598,024,052.97620,689,059.36
净利润273,070,841.15175,713,965.1683,572,615.29531,162,206
每股收益
其他综合收益-233,627.67-89,167.78-35,824.27280,702.14
综合收益总额272,837,213.48175,624,797.3883,536,791.02531,442,908.14
资产负债表
报告期2025-09-302025-06-302025-03-312024-12-31
流动资产:
流动资产合计2,429,825,802.082,447,221,182.222,588,263,932.262,580,998,523.17
非流动资产:
非流动资产合计2,865,220,909.022,994,802,970.283,043,193,655.962,993,966,639.18
资产总计5,295,046,711.15,442,024,152.55,631,457,588.225,574,965,162.35
流动负债:
流动负债合计208,320,430.35208,697,977.56244,861,231.38278,129,608.55
非流动负债:
非流动负债合计1,091,493,781.231,160,540,629.71,171,985,800.331,164,035,605.41
负债合计1,299,814,211.581,369,238,607.261,416,847,031.711,442,165,213.96
所有者权益(或股东权益):
归属于母公司股东权益合计4,000,375,714.954,078,022,542.144,219,983,288.434,138,374,136.02
股东权益合计3,995,232,499.524,072,785,545.244,214,610,556.514,132,799,948.39
负债和股东权益合计5,295,046,711.15,442,024,152.55,631,457,588.225,574,965,162.35
现金流量表
报告期2025-09-302025-06-302025-03-312024-12-31
经营活动产生的现金流量:
经营活动现金流入小计1,209,072,997.52798,356,728.95366,407,557.921,891,598,392.21
经营活动现金流出小计782,239,426.33554,280,078.23295,460,843.411,277,586,462.95
经营活动产生的现金流量净额426,833,571.19244,076,650.7270,946,714.51614,011,929.26
投资活动产生的现金流量:
投资活动现金流入小计43,724,876.2743,153,085.7188,602,966.24672,307,553.42
投资活动现金流出小计293,312,420.48236,083,794.81137,138,675.41690,927,208.69
投资活动产生的现金流量净额-249,587,544.21-192,930,709.1-48,535,709.17-18,619,655.27
筹资活动产生的现金流量:
筹资活动现金流入小计6,168,419.444,433,931.57754,865.6129,258,866.27
筹资活动现金流出小计570,488,806.53285,229,023.74,002,806.41205,739,197.57
筹资活动产生的现金流量净额-564,320,387.09-280,795,092.13-3,247,940.8-176,480,331.3
汇率变动对现金及现金等价物的影响-164,996.95-72,861.86-31,821.43515,978.68
现金及现金等价物净增加额-387,239,357.06-229,722,012.3719,131,243.11419,427,921.37
期末现金及现金等价物余额743,819,044.78901,336,389.471,061,788,964.421,131,058,401.84
补充资料:
现金及现金等价物的净增加额--229,722,012.37-419,427,921.37
最新报告期:2025-09-05
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
中泰证券谢木青0.700.860.982025-09-05
TOP↑